You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Droperidol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for droperidol and what is the scope of patent protection?

Droperidol is the generic ingredient in four branded drugs marketed by Abraxis Pharm, Am Regent, Astrazeneca, Hikma, Hospira, Igi Labs Inc, Luitpold, Smith And Nephew, Solopak, Watson Labs, Rising, and Epic Pharma Llc, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for droperidol. Two suppliers are listed for this compound.

Summary for droperidol
US Patents:0
Tradenames:4
Applicants:12
NDAs:24
Drug Master File Entries: 5
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 102
Clinical Trials: 43
Patent Applications: 6,667
What excipients (inactive ingredients) are in droperidol?droperidol excipients list
DailyMed Link:droperidol at DailyMed
Recent Clinical Trials for droperidol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
RenJi HospitalN/A
Mercy Health OhioPhase 3
Lake Erie College of Osteopathic MedicinePhase 3

See all droperidol clinical trials

Pharmacology for droperidol
Medical Subject Heading (MeSH) Categories for droperidol
Anatomical Therapeutic Chemical (ATC) Classes for droperidol

US Patents and Regulatory Information for droperidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Igi Labs Inc DROPERIDOL droperidol INJECTABLE;INJECTION 072020-001 Oct 19, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Igi Labs Inc DROPERIDOL droperidol INJECTABLE;INJECTION 072019-001 Oct 19, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hospira DROPERIDOL droperidol INJECTABLE;INJECTION 071645-001 Apr 7, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.